APOE and Alzheimer disease: NMZ successfully attenuated the hallmarks of AD pathology and rescued cognitive deficits in different mouse models of AD including three familial AD models (APP/PS1, 3xTg, APOE4) and a novel model of sporadic Aldh2–/– AD mice in different ways (Luo et al., 2016).